BCDA Stock BCDA is expected to report earnings to fall -122% to -20 cents per share on May 14

A.I.dvisor
at Tickeron.com
05/13/24
Loading...
BCDA - BioCardia
BioCardia Earnings Graph
Q1'24
Est.
$-0.20
Q4'23
Beat
by $0.02
Q3'23
Beat
by $0.02
Q2'23
Missed
by $0.02
Q1'23
Missed
by $0.01
The last earnings report on December 31 showed earnings per share of -9 cents, beating the estimate of -11 cents. P/B Ratio (0.000) is normal, around the industry mean (10.609). P/E Ratio (0.000) is within average values for comparable stocks, (160.883). BCDA's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.422). Dividend Yield (0.000) settles around the average of (0.066) among similar stocks. P/S Ratio (17.575) is also within normal values, averaging (236.959). With 32.22K shares outstanding, the current market capitalization sits at 10.64M.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage regenerative medicine company, which develops novel therapeutics for cardiovascular diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com